HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mathew J Garnett Selected Research

BDP9066

1/2018Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mathew J Garnett Research Topics

Disease

53Neoplasms (Cancer)
04/2024 - 06/2002
5Breast Neoplasms (Breast Cancer)
11/2022 - 01/2016
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 01/2018
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2017
3Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2019
2Microsatellite Instability
01/2021 - 01/2019
2Oncogene Addiction
01/2020 - 03/2012
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 01/2018
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019 - 04/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 07/2015
2Neuroblastoma
02/2016 - 01/2015
2Hypersensitivity (Allergy)
01/2016 - 01/2015
2Melanoma (Melanoma, Malignant)
01/2015 - 06/2002
2Ewing Sarcoma (Sarcoma, Ewing)
01/2015 - 03/2012
1Infections
01/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023
1Inflammation (Inflammations)
01/2023
1Colonic Neoplasms (Colon Cancer)
01/2022
1Malignant Mesothelioma
11/2021
1Drug-Related Side Effects and Adverse Reactions
01/2021
1Thrombocytopenia (Thrombopenia)
12/2020
1Myotonic Dystrophy (Dystrophia Myotonica)
01/2018
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2018
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018
1Adenocarcinoma
01/2018
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018
1Sclerosis
01/2018
1Skin Neoplasms (Skin Cancer)
01/2018
1Leukemia
01/2018
1Hodgkin Disease (Hodgkin's Disease)
01/2018
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1Multiple Myeloma
01/2018
1Liver Neoplasms (Liver Cancer)
12/2017
1Glioblastoma (Glioblastoma Multiforme)
01/2017

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2012
7Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2004
5DNA (Deoxyribonucleic Acid)IBA
04/2024 - 01/2015
5Drug CombinationsIBA
03/2024 - 11/2015
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 12/2005
3Phosphotransferases (Kinase)IBA
01/2018 - 03/2004
2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2021
2AZD8186IBA
11/2022 - 04/2016
2capivasertibIBA
11/2022 - 04/2016
2ProteomeIBA
01/2022 - 11/2019
2venetoclaxIBA
12/2020 - 02/2016
2Mechanistic Target of Rapamycin Complex 1IBA
01/2019 - 04/2016
2TIC10 compoundIBA
01/2018 - 01/2017
2Protein Isoforms (Isoforms)IBA
04/2016 - 10/2004
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2015 - 03/2012
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2015 - 03/2012
1AdenineFDA LinkGeneric
01/2023
1InterferonsIBA
01/2023
1CytidineIBA
01/2023
1Procainamide (Procan)FDA LinkGeneric
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
01/2022
1SuspensionsIBA
01/2022
1NucleotidesIBA
11/2021
1karonudibIBA
11/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1AsbestosIBA
11/2021
1AZD-0364IBA
01/2021
1bis(p-chlorophenyl)acetic acid (DDA)IBA
01/2021
1AZD 6244IBA
01/2021
1olaparibIBA
01/2021
1AZD4320IBA
12/2020
1Pharmacological BiomarkersIBA
12/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2019
1ONC212IBA
12/2019
1Werner Syndrome HelicaseIBA
01/2019
1MTOR InhibitorsIBA
01/2019
1navitoclaxIBA
01/2019
1Myosins (Myosin)IBA
01/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1Itraconazole (Sporanox)FDA LinkGeneric
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Bortezomib (Velcade)FDA Link
01/2018
1BDP9066IBA
01/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2018
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018
1Therapeutic UsesIBA
01/2018
1MutagensIBA
01/2018
1SCH772984IBA
12/2017
1PhosphoproteinsIBA
01/2017
1AZD8835IBA
04/2016
1vistusertibIBA
04/2016
1Aurora Kinase AIBA
02/2016

Therapy/Procedure

25Therapeutics
03/2021 - 03/2012
4Precision Medicine
09/2021 - 01/2017
2Drug Therapy (Chemotherapy)
01/2021 - 01/2021
1Antineoplastic Combined Chemotherapy Protocols
03/2024
1Transcutaneous Electric Nerve Stimulation (TENS)
01/2022
1Immunotherapy
01/2021